Sumitomo Mitsui DS Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
BTW
CIM
RP
CFM
PFSRSONJ
JIC
IHL
Sumitomo Mitsui DS Asset Management's CRL Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management increased its Charles River Laboratories (CRL) stake by 38% in Q2 2026, buying an estimated $85.5K and bringing the position to 1,751 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #697.
Sumitomo Mitsui DS Asset Management first reported a position in CRL in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.33M in Q4 2021. 125 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 1,751 shares of Charles River Laboratories worth $397K as of Q2 2026.
- Sumitomo Mitsui DS Asset Management bought 480 Charles River Laboratories shares in Q2 2026, an estimated $85.5K.
- Charles River Laboratories made up ﹤0.01% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #697 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Charles River Laboratories in Q2 2021 and has held it in 19 quarters since.
- Sumitomo Mitsui DS Asset Management's Charles River Laboratories position peaked at $1.33M in Q4 2021.
- 125 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.